skip to main content, skip to Quick links, or skip to Search

Vector Borne Disease Diagnostic Laboratory

 

**To the client base of the VBDDL at NCSU CVM**

50% Discount!

               We’re letting the Cat out of the Bag!
                  **New test offering: March 2014

Vector Borne Disease Awareness Week is March 23-29, 2014

In a time of shrinking budgets, the Vector Borne Disease Diagnostic Laboratory at CVM-NCSU is striving to help you and your clients stretch your dollar and get more for less in the detection of exposure to multiple pathogens rather than targeting one disease and potentially overlooking co-infecting or hidden disease processes that may affect treatment or management strategies in your patients. In January 2013, we made available the Canine Comprehensive Panel that detects antibodies against 12 known species and detects the presence, within circulating blood, of disease-causing organisms from 5 pathogenic genera.  We offered this $385 value at a greater than *50% discount*. Results of recent studies (Ref A. Birkenheuer abstract ID-2 at 2013 ACVIM and Maggi et al, in press, Parasites and Vectors, 2014) support the use of PCR and serological assays in parallel as likely to increase the detection of infection with, or exposure to, Canine Vector Borne Diseases, up to 60% in some populations of vector exposed dogs.

There was then an outcry of interest from referring veterinarians for a similar panel for the diagnosis of feline vector borne diseases. So, in September 2013, we made available a Feline Comprehensive Panel at the same drastically discounted price of $175! The panel for cats varies appropriately from that offered for dogs to target by PCR Cytauxzoonsis in addition to Anaplasmosis, Babesia, Bartonellosis, and Hemotropic Mycoplasma. PCR for Ehrlichiosis and Rickettsiosis were included to determine whether these genera may be playing an unrecognized role in cats. The serology (IFA) component of this panel targets three known Bartonella species carried by and potentially transmitted zoonotically by cats, B.henselae, B. vinsonii subspecies berkhoffii and B. koehlerae. Based upon a recent serological survey we performed on 715 feline sera from cats with suspected vector borne illness from our accessions (manuscript in preparation) and based upon some of the PCR data from the feline comprehensive panel to date, we believe cats are being exposed to all the Ehrlichia and Anaplasma species that are infecting their canine colleagues at rates of 1-5% per year. **Therefore effective March 2014, we will be adding to the Feline Comprehensive Panel, at no extra charge, serological testing (ELISA) for Ehrlichia, Anaplasma, Borrelia and Heartworm.** Comprehensive Feline Panel submissions will automatically be tested and results reported to referring veterinarians. Interpretation of results as they apply to individual cases will rely upon the referring veterinarian’s judgment based upon the clinical signs and symptoms with which any individual animal presents. This testing will be restricted to cases on which the full feline comprehensive panel is requested.

Samples to send: paired serum and EDTA whole blood (2mls each). To submit samples for testing through our lab, please download our most recent TEST REQUEST FORM with instructions.

lab staff

VBDDL logo

 

Donations

 

Staff Members

Clinical Advisors:

Scientific Advisors:

Lab Supervisor:

Barbara Hegarty, BA

Sample Receiving and Reporting:

Jackie York

Bartonella, Borrelia, and Rickettsia Serology Testing:

Julie Bradley, RVMT, and Patricia Faw, MLT

Babesia, Ehrlichia, and Leishmania Serology Testing:

Kaye Gore, MLT

Molecular (PCR) Testing

Brittany Thomas, BS

Statement of Intent - VBDDL, IPRL 3-13-2011

It is our intention to give each case with which we become involved the highest quality and attention possible. We will handle the sample with care and appropriate speed to obtain the most informative and accurate result. We intend to collect and utilize descriptive information imparted with that sample (address, age, breed, sex, history) in ways that reveal the useful and pertinent context for the diseases we study without using information in any way that might insult or harm the animal, owner, or veterinarian concerned.

Legal Notice

The focus of the NCSU VBDDL is research to benefit animal health.  It is our intention to provide quality answers to diagnostic questions.  The assays, antigens and controls used are developed and validated as a component of our research. We reserve the right to modify methods or reagents as needed to achieve the best analysis possible without reliance on any proprietary method or reagents.

Webcasts and Podcasts from the VBDDL

Return to Top